Panitumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Panitumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about NationDrugs.to
List of countries where we can ship Panitumumab:
Latest news releases on Panitumumab:
Panitumumab , formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and ...
Learn about Vectibix (Panitumumab Injection for Intravenous Use) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and ...
Vectibix treats metastatic colorectal cancer that has progressed after treatment with other chemotherapy. Learn about side effects, interactions and indications.
BackgroundPatients with metastatic colorectal cancer that harbors KRAS mutations in exon 2 do not benefit from anti–epidermal growth factor receptor (EGFR) therapy.
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
Notes: The three weekly panitumumab regimen has been used in select patients. Drug status: Panitumumab is PBS authority. Cost: ~ $2,430 per cycle "How this cost is ...
Learn about Vectibix® (panitumumab), a treatment option for wild-type RAS metastatic colorectal cancer. See Prescribing Information and Boxed Warning.
Participants received panitumumab, 6 mg/kg on Day 1 and FOLFOX chemotherapy regimen on Days 1 and 2 of each 14-day cycle until disease progression or unacceptable ...
Evidence-based recommendations on cetuximab (Erbitux) and panitumumab (Vectibix) for previously untreated RAS wild-type metastatic colorectal cancer in adults